Lawrence N. Tanenbaum, MD FACR is Vice President/Chief Technology Officer Director of CT, MR, and Advanced Imaging for RadNet with 37+ years experience in the medical field. He is a member of editorial boards of several journals/educational organizations and reviewer for scientific journals. He has authored 100+ scholarly and peer-reviewed articles, chairs educational/academic meetings, and has delivered 2000+ invited global lectures.

Lawrence N. Tanenbaum, MD FACR is Vice President/Chief Technology Officer Director of CT, MR, and Advanced Imaging for RadNet with 37+ years experience in the medical field. He is a member of editorial boards of several journals/educational organizations and reviewer for scientific journals. He has authored 100+ scholarly and peer-reviewed articles, chairs educational/academic meetings, and has delivered 2000+ invited global lectures.*

*Dr. Tanenbaum is a consultant of GE Healthcare.


Product Indications and Use:
CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine, and associated tissues in adult and pediatric patients (including term neonates) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity.

Important Safety Information About CLARISCAN:
Contraindications
History of clinically important hypersensitivity reactions to Clariscan

Read the complete case study here

 

 


Related Content

News | Pediatric Imaging

September 29, 2022 — According to an open-access Editor’s Choice article in ARRS’ American Journal of Roentgenology (AJR ...

Time September 29, 2022
arrow
News | Radiology Imaging

September 27, 2022 — UK Biobank, the large-scale biomedical database and research resource, together with the Medical ...

Time September 27, 2022
arrow
News | Contrast Media

Editor’s note: On September 21, 2022, both Guerbet and Bracco Diagnostics released news detailing the FDA approval of a ...

Time September 22, 2022
arrow
News | Contrast Media

September 21, 2022 – Guerbet, a global medical imaging company, has announced that the U.S. Food and Drug Administration ...

Time September 21, 2022
arrow
Feature | Magnetic Resonance Imaging (MRI) | By Shweta Sarnaik

Magnetic resonance imaging (MRI) is used to assess, identify and track a variety of medical disorders. Radio waves, a ...

Time September 15, 2022
arrow
Feature | Contrast Media | By Sheela Agarwal, MD, MBA

“Zero-COVID” policies have had a massive impact around the world. One consequence has been the recent global shortage in ...

Time September 14, 2022
arrow
Feature | Contrast Media | By Christine Book

The theme “Everyday progress” seems appropriate for the imaging community in 2022. What a year it’s been. Supply ...

Time September 14, 2022
arrow
News | Radiology Business

September 6, 2022 — The American College of Radiology (ACR) Computed Tomography (CT) and Magnetic Resonance Imaging (MRI ...

Time September 06, 2022
arrow
News | Radiology Imaging

August 29, 2022 — Indian River State College (IRSC) joined with executives from Fujifilm Healthcare Americas Corporation ...

Time August 29, 2022
arrow
Feature | Magnetic Resonance Imaging (MRI) | Christine Book

August 10, 2022 — The imaging community has lost a legend, recognized for having revolutionized the field of diagnostic ...

Time August 10, 2022
arrow
Subscribe Now